Grossman Jerrold B's Form 4 filing
Adma Biologics, Inc. (ADMA) · filed Aug 30, 2023
- Accession no.
- 0001140361-23-041848
- Filed
- Aug 30, 2023
- Trade date
- Aug 30, 2023
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market purchases total $482.3K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Grossman Jerrold BCIK 0001542519 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 30, 2023 | Common Stock | PPurchaseAcquired | +130,000 | $3.71F1 | +$482,300 | 443,265 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Reflects the weighted average price of purchases on August 30, 2023. The shares were purchased in multiple transactions ranging from $3.70 to $3.71, inclusive.
Referenced by the price of 1 transaction in Table I.